| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |